Study of Safety and Effects of MDMA-assisted Therapy for Treatment of PTSD

Summary

The purpose of this clinical trial is to learn if MDMA-assisted therapy is safe and effective in people with PTSD. The main question it aims to answer is: Do two open-label sessions of MDMA-assisted therapy reduce PTSD symptoms? Participants will undergo three non-drug preparatory therapy sessions followed by two open-label MDMA-assisted therapy sessions. After, participants will undergo three non-drug integrative therapy sessions.

Timeline

Start

2022-08

Primary completion

2023-08

Completion

2023-08

Drugs

Indications